• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用瞬时弹性成像技术对门静脉高压进行非侵入性评估。

Non invasive evaluation of portal hypertension using transient elastography.

机构信息

Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Université Denis Diderot Paris VII, Clichy, France.

出版信息

J Hepatol. 2012 Mar;56(3):696-703. doi: 10.1016/j.jhep.2011.07.005. Epub 2011 Jul 20.

DOI:10.1016/j.jhep.2011.07.005
PMID:21767510
Abstract

The development of portal hypertension is a common consequence of chronic liver diseases leading to the formation of esophageal and gastric varices responsible for variceal bleeding, associated with a high mortality rate, as well as other severe complications such as portosystemic encephalopathy and sepsis. Measurement of hepatic venous pressure gradient (HVPG) and upper GI endoscopy are considered the gold standards for portal hypertension assessment in patients with cirrhosis. However, both types of investigation are invasive and HVPG measurement is routinely available and/or performed with adequate standards only in expert centres. There is thus a need for non invasive methods able to predict, with acceptable diagnostic accuracy, the progression of portal hypertension toward the levels of clinically significant (i.e. HVPG ≥ 10 mmHg) and severe (HVPG ≥ 12 mmHg) as well as the presence and the size of oesophageal varices. Transient elastography (TE) is a novel non invasive technology that allows measuring liver stiffness and that has gained popularity over the past few years. Although TE has been initially proposed to assess liver fibrosis, a good correlation has been reported between liver stiffness values and HVPG as well as the presence of oesophageal varices, suggesting that it could be an interesting tool for the non invasive evaluation of portal hypertension. This review is aimed at discussing the advantages and limits of TE and the perspectives for its rationale use in clinical practice for the management of patients with portal hypertension.

摘要

门静脉高压症的发展是慢性肝病的常见后果,导致食管和胃静脉曲张的形成,这些静脉曲张负责静脉曲张出血,伴有高死亡率,以及其他严重并发症,如门脉系统脑病和脓毒症。肝静脉压力梯度(HVPG)测量和上消化道内镜检查被认为是肝硬化患者门静脉高压评估的金标准。然而,这两种类型的检查都是侵入性的,HVPG 测量通常仅在专家中心以足够的标准进行常规使用和/或进行。因此,需要有非侵入性的方法,能够以可接受的诊断准确性预测门静脉高压向临床显著水平(即 HVPG≥10mmHg)和严重水平(HVPG≥12mmHg)的进展,以及预测食管静脉曲张的存在和大小。瞬时弹性成像(TE)是一种新型的非侵入性技术,可用于测量肝脏硬度,并在过去几年中得到了普及。尽管 TE 最初被提议用于评估肝纤维化,但已经报道了肝脏硬度值与 HVPG 以及食管静脉曲张的存在之间存在良好的相关性,这表明它可能是一种用于门静脉高压无创评估的有趣工具。这篇综述旨在讨论 TE 的优点和局限性,以及在门静脉高压患者的管理中合理使用 TE 的前景。

相似文献

1
Non invasive evaluation of portal hypertension using transient elastography.使用瞬时弹性成像技术对门静脉高压进行非侵入性评估。
J Hepatol. 2012 Mar;56(3):696-703. doi: 10.1016/j.jhep.2011.07.005. Epub 2011 Jul 20.
2
Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.肝脏硬度准确预测慢性肝病患者门静脉高压相关并发症:一项前瞻性研究。
J Hepatol. 2011 Nov;55(5):1017-24. doi: 10.1016/j.jhep.2011.01.051. Epub 2011 Feb 25.
3
[Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].[瞬时弹性成像作为肝硬化患者食管静脉曲张的预测指标]
Orv Hetil. 2014 Feb 16;155(7):270-6. doi: 10.1556/OH.2014.29824.
4
Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.血清学检测、肝脏硬度检测和人工神经网络在肝硬化和门静脉高压症诊断中的应用。
Dig Liver Dis. 2015 May;47(5):411-6. doi: 10.1016/j.dld.2015.02.001. Epub 2015 Feb 7.
5
Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.无症状肝病患者的常规数据和肝硬度检测早期门静脉高压:一项前瞻性研究。
J Hepatol. 2014 Mar;60(3):561-9. doi: 10.1016/j.jhep.2013.10.027. Epub 2013 Nov 6.
6
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.肝脏硬度测量可预测丙型肝炎病毒相关性肝硬化患者的严重门静脉高压。
Hepatology. 2007 May;45(5):1290-7. doi: 10.1002/hep.21665.
7
Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.应用瞬时弹性成像技术(FibroScan®)无创评估 HIV/HCV 合并感染患者的门静脉高压。
J Viral Hepat. 2011 Oct;18(10):685-91. doi: 10.1111/j.1365-2893.2010.01371.x. Epub 2010 Sep 7.
8
Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.预测晚期纤维化患者临床显著门静脉高压的非侵入性模型。
J Gastroenterol Hepatol. 2009 Jul;24(7):1289-93. doi: 10.1111/j.1440-1746.2009.05904.x.
9
Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease.瞬时弹性成像:慢性肝脏疾病中门静脉高压评估的诊断准确性的荟萃分析。
Liver Int. 2013 Jan;33(1):62-71. doi: 10.1111/liv.12003. Epub 2012 Sep 14.
10
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study.脾脏硬度测量可预测代偿期 HCV 相关肝硬化的临床并发症:一项前瞻性研究。
J Hepatol. 2014 Jun;60(6):1158-64. doi: 10.1016/j.jhep.2014.02.024. Epub 2014 Mar 6.

引用本文的文献

1
A novel noninvasive assessment of portal pressure from computational biofluid mechanics in patients with portal hypertension.一种基于计算生物流体力学对门静脉高压症患者门静脉压力进行的新型无创评估方法。
Trials. 2025 May 21;26(1):167. doi: 10.1186/s13063-025-08818-6.
2
Visualizing global progress and challenges in esophagogastric variceal bleeding.可视化食管胃静脉曲张出血的全球进展与挑战。
World J Gastrointest Surg. 2025 Apr 27;17(4):102020. doi: 10.4240/wjgs.v17.i4.102020.
3
ICG-r15 predicts esophageal varices in compensated liver cirrhosis: a noninvasive approach.
ICG-r15 可预测代偿期肝硬化食管静脉曲张:一种无创方法。
BMC Gastroenterol. 2024 Nov 1;24(1):390. doi: 10.1186/s12876-024-03407-4.
4
Non-invasive assessment of esophageal and fundic varices in patients with primary biliary cholangitis.原发性胆汁性胆管炎患者食管和胃底静脉曲张的无创评估
Eur Radiol. 2025 Apr;35(4):2330-2338. doi: 10.1007/s00330-024-11049-z. Epub 2024 Sep 11.
5
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.KASL慢性肝病肝纤维化评估无创检测临床实践指南。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S5-S105. doi: 10.3350/cmh.2024.0506. Epub 2024 Aug 19.
6
A clinical-radiomics nomogram for the prediction of the risk of upper gastrointestinal bleeding in patients with decompensated cirrhosis.用于预测失代偿期肝硬化患者上消化道出血风险的临床-影像组学列线图。
Front Med (Lausanne). 2024 Jul 31;11:1308435. doi: 10.3389/fmed.2024.1308435. eCollection 2024.
7
Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.慢性肝病门静脉高压症发病机制及临床评估的新进展。
Gut Liver. 2024 Jan 15;18(1):27-39. doi: 10.5009/gnl230072. Epub 2023 Oct 16.
8
High correlation of hepatic shear wave velocity with esophageal varices complication rate in patients with chronic liver diseases.慢性肝病患者肝剪切波速度与食管静脉曲张并发症发生率的高度相关性。
BMC Gastroenterol. 2023 May 22;23(1):169. doi: 10.1186/s12876-023-02821-4.
9
The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis.两项 II 期临床试验的基本原理和研究设计,旨在研究可溶性鸟苷酸环化酶激活剂 BI 685,509 对代偿性肝硬化患者临床显著门静脉高压的影响。
Trials. 2023 Apr 24;24(1):293. doi: 10.1186/s13063-023-07291-3.
10
Current clinical understanding and effectiveness of portopulmonary hypertension treatment.门肺高压治疗的当前临床认识及疗效
Front Med (Lausanne). 2023 Apr 4;10:1142836. doi: 10.3389/fmed.2023.1142836. eCollection 2023.